Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionNeuronal nicotinic receptor modulator
Molecular Target Nicotinic receptor
Mechanism of ActionNicotinic receptor modulator
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationCognitive dysfunction
Indication DetailsTreat cognitive dysfunction
Regulatory Designation
PartnerNeuroSearch A/S

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today